2020 HOPA Annual Meeting
Pharmacists’ education on cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor (HR) positive/human ...
Patients who do not receive prophylaxis against central nervous system (CNS) disease during treatment for acute ...
A study found that patients with cancer at end of life (defined as last two weeks of life) may be receiving chemotherapy ...
Targeted therapies have changed the cancer treatment paradigm; however, obtaining off-label coverage of these therapies ...
Among pediatric patients with acute lymphocytic leukemia (ALL) and lymphocytic lymphoma (LL), asparagine depletion with ...
The addition of counseling sessions provided by the oncology clinical pharmacist improved patient satisfaction among ...
A study found that use of direct oral anticoagulants (DOACs) significantly decreased recurrent venous thromboembolism ...
Previous research has indicated that many patient groups are underrepresented in cancer clinical trials. Researchers ...
Researchers assessed the implementation of specialized financial accounting and pharmacy technician personnel to provide ...
Researchers assessed adverse event (AE)-related costs associated with U.S. Food and Drug Administration ...
Oncology infusion drugs are a costly expenditure, and the Hematology/Oncology Pharmacy Association (HOPA) recommends ...
Researchers at Sanford Roger Maris Cancer Center observed an increase in cancer-directed medication inpatient ...
Advertisement
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.